Pre-print: Alzheimer’s-like remodeling of neuronal ryanodine receptor in COVID-19, Reiken et al, 2021

Andy · Feb 24, 2021

COVID-19, caused by SARS-CoV-2 involves multiple organs including cardiovascular, pulmonary and central nervous system. Understanding how SARS-CoV-2 infection afflicts diverse organ systems remains challenging1,2. Particularly vexing has been the problem posed by persistent organ dysfunction known as “long COVID,” which includes cognitive impairment3. Here we provide evidence linking SARS-CoV-2 infection to activation of TGF-ß signaling and oxidative overload. One consequence is oxidation of the ryanodine receptor/calcium (Ca2+) release channels (RyR) on the endo/sarcoplasmic (ER/SR) reticuli in heart, lung and brains of patients who succumbed to COVID-19. This depletes the channels of the stabilizing subunit calstabin2 causing them to leak Ca2+ which can promote heart failure4,5, pulmonary insufficiency 6 and cognitive and behavioral defects7–9. Ex-vivo treatment of heart, lung, and brain tissues from COVID-19 patients using a Rycal drug (ARM210)10 prevented calstabin2 loss and fixed the channel leak. Of particular interest is that neuropathological pathways activated downstream of leaky RyR2 channels in Alzheimer’s Disease (AD) patients were activated in COVID-19 patients. Thus, leaky RyR2 Ca2+ channels may play a role in COVID-19 pathophysiology and could be a therapeutic target for amelioration of some comorbidities associated with SARS-CoV-2 infection.
Click to expand...

Open access, https://www.biorxiv.org/content/10.1101/2021.02.18.431811v1.full

Log in or Sign up

Pre-print: Alzheimer’s-like remodeling of neuronal ryanodine receptor in COVID-19, Reiken et al, 2021

Andy Committee Member

Share This Page

Log in or Sign up

Pre-print: Alzheimer’s-like remodeling of neuronal ryanodine receptor in COVID-19, Reiken et al, 2021

Andy Committee Member

Share This Page

Useful Searches